Table. Trends in Age-Adjusted Overdose Death Rates per 100 000 (95% CI) Involving Methamphetaminea Among Adults Aged 25-54 Years by Sex and Race and Ethnicity.
2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | Trends | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Men | ||||||||||||
Overall US men | 1.8 (1.7 to 1.9) |
2.1 (2.0 to 2.2) |
2.9 (2.8 to 3.1) |
3.5 (3.3 to 3.6)b |
4.6 (4.4 to 4.8) |
6.1 (5.9 to 6.3) |
8.3 (8.0 to 8.5) |
10.1 (9.9 to 10.4) |
2011-2014: APC = 26.4 (14.5 to 39.4); P = .005 |
2014-2018: APC = 31.2 (27.1 to 35.4); P < .001 | 2011-2018: AAPC = 29.1 (25.5 to 32.8); P < .001 |
|
Non-Hispanic American Indian or Alaska Native | 5.6 (3.7 to 8.1) |
6.9 (4.8 to 9.7) |
7.6 (5.4 to 10.4) |
11.7 (9.0 to 15.1) |
12.2 (9.3 to 15.6) |
16.9 (13.6 to 20.9) |
19.0 (15.3 to 23.2) |
26.4 (21.9 to 31.9) |
2011-2018: APC = AAPC = 24.2 (23.0 to 25.5); P < .001 | |||
Non-Hispanic White | 2.2 (2.1 to 2.4) |
2.5 (2.4 to 2.7) |
3.6 (3.4 to 3.8) |
4.2 (4.0 to 4.4)b |
5.5 (5.2 to 5.7) |
7.5 (7.2 to 7.8) |
10.5 (10.2 to 10.8) |
12.6 (12.3 to 13.0) |
2011-2014: APC = 25.6 (8.3 to 45.6); P = .02 |
2014-2018: APC = 33.0 (26.6 to 39.7); P < .001 |
2011-2018: AAPC = 29.8 (24.3 to 35.4); P < .001 |
|
Non-Hispanic Black | 0.6 (0.5 to 0.8) |
0.7 (0.5 to 0.9) |
1.4 (1.1 to 1.6) |
1.5 (1.2 to 1.8) |
2.3 (2.0 to 2.7) |
3.4 (3.0 to 3.8) |
4.6 (4.1 to 5.1) |
6.4 (5.9 to 7.0) |
2011-2018: APC = AAPC = 41.4 (39.5 to 43.2); P < .001 | |||
Non-Hispanic Asian | 1.1 (0.7 to 1.5) |
1.5 (1.2 to 2.0) |
1.3 (1.0 to 1.7) |
1.3 (1.0 to 1.7)b |
2.0 (1.6 to 2.5) |
2.2 (1.7 to 2.7) |
3.0 (2.4 to 3.5) |
3.4 (2.9 to 4.0) |
2011-2014: APC = 5.0 (–15.6 to 30.8); P = .53 |
2014-2018: APC = 25.1 (15.8 to 35.1); P = .003 |
2011-2018: AAPC = 16.1 (8.9 to 23.7); P < .001 |
|
Hispanic | 1.4 (1.2 to 1.6) |
1.7 (1.4 to 1.9) |
2.3 (2.0 to 2.5) |
2.6 (2.3 to 2.9) |
3.4 (3.1 to 3.7) |
4.2 (3.8 to 4.6) |
5.2 (4.8 to 5.6) |
6.6 (6.1 to 7.0) |
2011-2018: APC = AAPC = 24.8 (24.4 to 25.3); P < .001 | |||
Women | ||||||||||||
Overall US women | 0.8 (0.8 to 0.9) |
1.0 (0.9 to 1.1) |
1.3 (1.2 to 1.4) |
1.5 (1.4 to 1.6) |
2.0 (1.9 to 2.1)b |
2.6 (2.4 to 2.7) |
3.6 (3.5 to 3.8) |
4.5 (4.3 to 4.7) |
2011-2015: APC = 24.4 (18.0 to 31.2); P < .001 |
2015-2018: APC = 33.2 (26.2 to 40.6); P < .001 |
2011-2018: AAPC = 28.1 (25.1 to 31.2); P < .001 |
2012-2018: AAPC = 28.9 (25.1 to 32.8); P < .001 |
Non-Hispanic American Indian or Alaska Native | NA | 3.6 (2.2 to 5.5) |
5.8 (3.9 to 8.3) |
5.4 (3.6 to 8.0) |
8.0 (5.8 to 10.8)b |
9.4 (6.9 to 12.3 |
13.9 (10.9 to 17.4) |
15.6 (12.3 to 19.4) |
2012-2015: APC = 22.4 (–11.4 to 69.0); P = .12 |
2015-2018: APC = 30.5 (7.3 to 58.7); P = .03 |
2012-2018: AAPC = 26.4 (15.9 to 37.7); P < .001 |
|
Non-Hispanic White | 1.1 (1.0 to 1.2) |
1.3 (1.2 to 1.4) |
1.7 (1.5 to 1.8) |
2.0 (1.9 to 2.1)b |
2.7 (2.5 to 2.8) |
3.6 (3.4 to 3.8) |
5.1 (4.8 to 5.3) |
6.2 (6.0 to 6.5) |
2011-2014: APC = 22.8 (10.4 to 36.6); P = .009 |
2014-2018: APC = 34.1 (29.5 to 38.9); P < .001 |
2011-2018: AAPC = 29.1 (25.2 to 33.2); P < .001 |
2012-2018: AAPC = 30.3 (20.6 to 40.8); P < .001 |
Non-Hispanic Black | NA | 0.2 (0.2 to 0.4) |
0.4 (0.3 to 0.6) |
0.5 (0.3 to 0.6) |
0.5 (0.4 to 0.7)b |
0.9 (0.7 to 1.1) |
1.2 (1.0 to 1.4) |
1.7 (1.4 to 2.0) |
2012-2015: APC = 27.8 (4.3 to 56.6); P = .04 |
2015-2018: APC = 43.6 (29.1 to 59.7); P = .005 |
2012-2018: AAPC = 35.5 (28.6 to 42.8); P < .001 |
|
Non-Hispanic Asian | NA | NA | 0.6 (0.4 to 1.0) |
NA | 0.5 (0.3 to 0.7) |
0.6 (0.4 to 0.9) |
0.6 (0.4 to 0.9) |
1.1 (0.8 to 1.4) |
Too few data points to conduct joinpoint trend analysis | |||
Hispanic | 0.5 (0.4 to 0.7) |
0.6 (0.5 to 0.8) |
0.8 (0.6 to 1.0) |
0.9 (0.7 to 1.1) |
1.3 (1.1 to 1.5) |
1.0 (0.8 to 1.2) |
1.7 (1.5 to 2.0) |
2.0 (1.7 to 2.2) |
2011-2018: APC = AAPC = 20.9 (16.7 to 25.3); P < .001 |
2012-2018: APC = AAPC = 20.4 (15.1 to 26.0); P < .001 |
Abbreviations: AAPC, average APC; APC, annual percentage change; NA, not applicable because there were too few cases to report reliable estimates.
Psychostimulants with abuse potential (predominantly responding to methamphetamine).
Joinpoint, which is identified in this year indicating significant changes in nonlinear trends using a bayesian information criterion.